Azerbaijan, Baku, Oct. 11 /Trend, T. Jafarov/
Iran is still grappling with a medicine shortage, Chief of Iran's Food and Drug Organization, Rasoul Dinarvand said, ISNA reported on Thursday.
According to him, the reason behind the medicine shortage is that the Central Bank of Iran delays the allocation of funds for the importation of drugs.
"The prices of imported medicines increased due to the growth in the rate of foreign currency. The price of medicine produced in the country also increased by 50 per cent," Dinarvand said.
Over $723 million were allocated for compensation and regulation. Some $200 million of these funds were allocated to the Ministry of Health.
International sanctions against Iran over its nuclear program have led to a significant increase in the rate of dollar rate against the Iranian rial in recent years.
This has led to a rise in price of drugs imported for patients suffering from serious diseases.
In recent years, Iran has had difficulty in getting 90 kinds of drugs for the treatment of cancer, diabetes, certain infections and other serious illnesses.